Aprea Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Aprea Therapeutics using advanced sorting and filters.
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Sep 2024 | 2024-11-07 | $-0.64 | $-0.72 | 11.1 % |
Jun 2024 | 2024-08-12 | $-0.58 | $-0.64 | 9.38 % |
Mar 2024 | 2024-05-14 | $-0.67 | $-0.78 | 14.1 % |
Dec 2023 | 2024-03-26 | $-0.92 | $-0.77 | -19.5 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Sep 2024 | 2024-11-07 | $354.62K | $225.00K | 57.6 % |
Jun 2024 | 2024-08-12 | $561.57K | $50.00K | 1023.2 % |
Dec 2023 | 2024-03-26 | $14.08K | $110.00K | -87.2 % |
Sep 2023 | 2023-11-09 | $319.47K | $80.00K | 299.3 % |
Aprea Therapeutics ({quoteSymbol}) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on November 7, 2024 for Q3.
Aprea Therapeutics ({quoteSymbol}) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on November 7, 2024 for Q3 and the Actual EPS was $-0.64, which beat the estimate of $-0.72.
Aprea Therapeutics ({quoteSymbol}) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on November 7, 2024 for Q3 and the Actual EPS was {{actualEPS}}, which beat the estimate of {{estEPS}}.
Browse earnings estimates, EPS, and revenue on all stocks.